Geneos Wealth Management’s State Street SPDR Portfolio Intermediate Term Corporate Bond ETF SPIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.01M Buy
89,839
+209
+0.2% +$7.06K 0.07% 292
2025
Q4
$3.03M Buy
89,630
+2,045
+2% +$69.3K 0.07% 289
2025
Q3
$2.97M Buy
87,585
+3,069
+4% +$103K 0.08% 283
2025
Q2
$2.84M Sell
84,516
-103,565
-55% -$3.43M 0.07% 306
2025
Q1
$6.25M Buy
188,081
+104,255
+124% +$3.44M 0.09% 271
2024
Q4
$2.75M Sell
83,826
-202
-0.2% -$6.69K 0.1% 231
2024
Q3
$2.83M Sell
84,028
-8,754
-9% -$291K 0.11% 222
2024
Q2
$3.02M Buy
92,782
+397
+0.4% +$12.9K 0.13% 178
2024
Q1
$3.02M Buy
92,385
+7,608
+9% +$248K 0.14% 184
2023
Q4
$2.78M Buy
84,777
+10,309
+14% +$328K 0.14% 178
2023
Q3
$2.34M Buy
74,468
+8,528
+13% +$272K 0.12% 187
2023
Q2
$2.12M Buy
65,940
+21,354
+48% +$690K 0.11% 210
2023
Q1
$1.45M Buy
44,586
+2,944
+7% +$95K 0.09% 244
2022
Q4
$1.33M Buy
41,642
+2,439
+6% +$77.1K 0.08% 229
2022
Q3
$1.23M Sell
39,203
-4,028
-9% -$131K 0.08% 221
2022
Q2
$1.42M Buy
43,231
+8,811
+26% +$291K 0.07% 255
2022
Q1
$1.18M Buy
34,420
+3,506
+11% +$123K 0.05% 316
2021
Q4
$1.12M Buy
30,914
+4,777
+18% +$173K 0.04% 367
2021
Q3
$956K Buy
26,137
+3,435
+15% +$126K 0.04% 394
2021
Q2
$832K Sell
22,702
-12,830
-36% -$468K 0.03% 420
2021
Q1
$1.29M Buy
35,532
+3,852
+12% +$141K 0.04% 357
2020
Q4
$628K Buy
31,680
+16,526
+109% +$610K 0.03% 474
2020
Q3
$555K Buy
15,154
+490
+3% +$18K 0.03% 402
2020
Q2
$533K Buy
14,664
+1,720
+13% +$61.2K 0.03% 399
2020
Q1
$435K Sell
12,944
-129,519
-91% -$4.54M 0.03% 401
2019
Q4
$5.03M Sell
142,463
-3,185
-2% -$112K 0.27% 107
2019
Q3
$5.13M Buy
145,648
+2,457
+2% +$86.2K 0.31% 84
2019
Q2
$5M Buy
143,191
+47,035
+49% +$1.61M 0.31% 85
2019
Q1
$3.29M Buy
96,156
+2,905
+3% +$97.6K 0.22% 123
2018
Q4
$3.08M Buy
93,251
+152
+0.2% +$5.01K 0.23% 119
2018
Q3
$3.1M Buy
93,099
+81,255
+686% +$2.71M 0.21% 138
2018
Q2
$394K Buy
11,844
+150
+1% +$4.99K 0.03% 371
2018
Q1
$392K Buy
11,694
+1,205
+11% +$40.6K 0.03% 355
2017
Q4
$358K Buy
10,489
+3,640
+53% +$125K 0.03% 393
2017
Q3
$236K Hold
6,849
0.02% 467
2017
Q2
$235K Buy
6,849
+900
+15% +$30.9K 0.02% 456
2017
Q1
$203K Sell
5,949
-73
-1% -$2.48K 0.02% 478
2016
Q4
$204K Hold
6,022
0.03% 453
2016
Q3
$210K Sell
6,022
-334
-5% -$11.6K 0.03% 436
2016
Q2
$221K Sell
6,356
-1,658
-21% -$57.1K 0.03% 411
2016
Q1
$274K Buy
+8,014
New +$270K 0.04% 359

Other funds holding SPIB

Geneos Wealth Management's SPIB Position: Q1 2026 in Review

Geneos Wealth Management increased its State Street SPDR Portfolio Intermediate Term Corporate Bond ETF (SPIB) stake by 0.23% in Q1 2026, buying an estimated $7.06K and bringing the position to 89,839 shares worth $3.01M. The position accounts for 0.07% of the portfolio, ranked #292.

Geneos Wealth Management first reported a position in SPIB in Q1 2016 and has held it in 41 quarters since. The position peaked at $6.25M in Q1 2025. 573 funds tracked by Wall St. Rank hold SPIB as of Q1 2026.

  • Geneos Wealth Management held 89,839 shares of State Street SPDR Portfolio Intermediate Term Corporate Bond ETF worth $3.01M as of Q1 2026.
  • Geneos Wealth Management bought 209 State Street SPDR Portfolio Intermediate Term Corporate Bond ETF shares in Q1 2026, an estimated $7.06K.
  • State Street SPDR Portfolio Intermediate Term Corporate Bond ETF made up 0.07% of Geneos Wealth Management's portfolio in Q1 2026, its #292 holding.
  • Geneos Wealth Management first reported a position in State Street SPDR Portfolio Intermediate Term Corporate Bond ETF in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's State Street SPDR Portfolio Intermediate Term Corporate Bond ETF position peaked at $6.25M in Q1 2025.
  • 573 funds tracked by Wall St. Rank held State Street SPDR Portfolio Intermediate Term Corporate Bond ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.